Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FRGZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,212
Award facts
- Contract value 100% obligated
- $4,212.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,212.40 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes on October 24, 2025, with completion targeted for October 27, 2025. This firm fixed-price delivery order, placed with no set-aside designation, represents a competitive procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle extending through December 2026. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office.
HEPLISAV-B is a recombinant hepatitis B vaccine used within the Defense Health Agency and military healthcare systems. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement, supplying vaccines, medications, and medical supplies to support military and veteran healthcare programs worldwide. The transaction reflects the company's competitive capability to fulfill federal medical supply requirements through its comprehensive pharmaceutical prime vendor agreement, which enables flexible ordering of brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FRGZX?
SPE2DB26FRGZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FRGZX worth?
The government has obligated $4,212 on SPE2DB26FRGZX.
Is contract SPE2DB26FRGZX an order under another contract?
Yes. SPE2DB26FRGZX is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB26FRGZX competed?
The extent of competition for SPE2DB26FRGZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award